logo
9 surprising things about French pharmacies

9 surprising things about French pharmacies

Local France28-03-2025

Pharmacies in France do all the things that you would expect, such as dealing with prescriptions and dispensing medicines. They also, as in many other countries, sell make-up, skincare products, sunscreen and baby items.
But there are some extra items and services in French pharmacies that often come as a surprise to foreigners.
Over the counter medicines
In France, only pharmacies are allowed to sell common over-the-counter remedies such as paracetamol, aspirin and cold and flu remedies. You cannot get these in supermarkets, petrol stations or grocery stores.
These medications often appear under different brand names in France - if you want a basic over-the-counter painkiller, ask for it by the brand name of Doliprane (which is paracetamol).
Consultations
Although over-the-counter remedies can be obtained without a prescription in France, they're stocked behind the counter so you will need to ask the pharmacist for what you want.
Depending on the medication it's common for them to ask you a few questions to make sure you're getting the best product - so if you have a cough and want a cough syrup, expect to be answering questions on the type of cough you have, how long you have had it and any other symptoms.
All pharmacies are required by law to have at least one fully qualified pharmacist on the premises at all times, and you can request to speak to them if you have a medical question.
Pharmacists are highly qualified so you can go to the pharmacy for a consultation on any aspect of your health - if the pharmacist thinks that it is beyond their area of expertise they will advise you to visit a doctor and can usually also point you in the right direction to find the best local health services.
Advertisement
READ ALSO
11 things you can do at a French pharmacy
First aid and medical services
The other thing that pharmacies offer is first aid services or treatment for injuries that aren't bad enough to need hospital treatment.
Likewise if you have visited a hospital and end up with a dressing that needs changing regularly or a similar ongoing need, you might be advised to go to a pharmacy and get it seen to.
The great advantage to using a pharmacy for this sort of service is that there is one on nearly every street in France (well not quite every,
but there are a lot
) and you don't need an appointment.
You can, however, make appointments for some of the other things that pharmacies offer - including giving vaccines for Covid or flu, testing for tonsillitis/strep throat or urinary tract infections. Since 2023, pharmacists
have been able to dispense antibiotics
without a prescription following a positive tonsillitis or urinary tract infection test.
Heavy legs products
If you're in a pharmacy in the summer you're also likely to see a shelf of products for
les jambes lourds
(heavy legs). This
appears to be an ailment suffered only by Frenchwomen
and pharmacies are very keen on providing - and advertising - products to deal with it.
These are mostly heavy-duty stockings to improve the blood flow in the legs, but there are also numerous herbal remedies that make slightly dubious claims about heavy legs.
Teas
Which brings us to tea - you can buy a lot of different types of tea in a French pharmacy, mostly herbal teas or
tisanes
. Some of these make vaguely health-related claims promising to aid digestion, sleep or circulation, others just have nice flavours.
In fact, you'll find a huge variety of herbal remedies, vitamins and food supplements available in most French pharmacies. The French are also devotees of homeopathy, which until recently was reimbursed by the health system. That's no longer the case, but homeopathic remedies abound in pharmacies.
Advertisement
They'll check your mushrooms
No, this isn't a medical procedure, but if you have been foraging for mushrooms, French pharmacies will check your haul to ensure that you haven't accidentally picked any dangerous ones.
Skincare might be surprisingly cheap
Like most countries, French pharmacies often have a big range of make-up, skincare and beauty products, including the big French brand names.
If you're coming from the US, you're likely to find these considerably cheaper - this isn't really a surprise if it's a French brand but the price difference is enough to make French pharmacies
something of a TikTok trend
.
Crowds
Perhaps for all the reasons outlined above, French pharmacies tend to be busy places, and you'll likely have to wait if you want a consultation.
The people in front of you in the queue probably won't be in too much of a hurry and if you eavesdrop on their conversation (which you're doing purely to improve your colloquial French, by the way) you might notice that there doesn't seem to be that much wrong with them. It's almost as if they're just there for a day out.
After a few years in France you'll stop finding this weird and start to wonder whether Saturday would be a good day for a nice trip to the pharmacy to stock up some tea and heavy legs stockings.
Advertisement
Useful vocab
La pharmacie
- the pharmacy
Le pharmacien
- the pharmacist
La parapharmacie
- the 'para' pharmacy is one that cannot dispense medicines, and only sells health and wellbeing products. They also do not offer consultations or medical services
La pharmacie de garde
- the on-duty pharmacy. Most pharmacies close on Sundays and public holidays, but there is a rota to ensure that one stays open in each area. You can google
pharmacie de garde
+ the name of your commune to find the nearest open pharmacy on a Sunday or holiday.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US restores some medical research grants, says top Trump official
US restores some medical research grants, says top Trump official

France 24

time12 hours ago

  • France 24

US restores some medical research grants, says top Trump official

Jay Bhattacharya, director of the National Institutes of Health (NIH), made the remarks during a Senate committee hearing examining both recent cuts to his agency and deeper reductions proposed by the White House in next year's budget. Bhattachartya said he had created an appeals process for scientists and laboratories whose research was impacted, and that the NIH had already "reversed many" of the cuts. "I didn't take this job to terminate grants," said the physician and health economist who left a professorship at Stanford University to join the Trump administration. "I took this job to make sure that we do the research that advances the health needs of the American people." The hearing came a day after more than 60 NIH employees sent an open letter to Bhattacharya condemning policies they said undermined the agency's mission and the health of Americans. They dubbed it the "Bethesda Declaration" -- a nod both to the NIH's suburban Washington headquarters and to Bhattacharya's role as a prominent signatory of the 2020 "Great Barrington Declaration," which opposed Covid lockdowns. Since Trump's January 20 inauguration, the NIH has terminated 2,100 research grants totaling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch. Affected projects include studies on gender, the health effects of global warming, Alzheimer's disease, and cancer.

Video misleads about safety of 6-in-1 vaccine Vaxelis
Video misleads about safety of 6-in-1 vaccine Vaxelis

AFP

time14 hours ago

  • AFP

Video misleads about safety of 6-in-1 vaccine Vaxelis

"A new vaccine is on the market for your 6 week old baby! It's never been tested against a placebo or for carcinogenic effects," claims a May 19, 2025 Instagram post from a Canadian content creator who regularly posts against vaccination. She is one of several creators who stitched their reactions next to a video with thousands of interactions from Jeffrey Barke, a founding member of America's Frontline Doctors -- a group AFP has repeatedly fact-checked. In the video, Barke reads from the package insert for Vaxelis, a shot given to simultaneously prevent infections caused by pertussis, diphtheria, tetanus, poliomyelitis, Haemophilus influenzae type b, and hepatitis B (archived here). "Studies that brought this product to market -- there is not a single randomized controlled study with an inert placebo. It's only tested against other vaccinations," he says, implying this is cause for concern. Image Screenshot of Instagram reels taken on June 3, 2025 Similar claims also appeared on X in French, German, Spanish and Croatian, spreading as officials with the US Department of Health and Human Services under Robert F. Kennedy, Jr. aim to shift the way vaccines are tested and approved. The posts also come as experts say vaccine misinformation is rampant online and may be contributing to falling vaccination rates across the United States and Canada (archived here and here). Vaxelis is not new, however. The US Food and Drug Administration first approved the joint venture of pharmaceutical companies Sanofi Pasteur and Merck for children six weeks through four years of age in December 2018 (archived here and here). It is also administered in Europe (archived here). Kelly Moore, president and CEO of the nonprofit co-authored the policy statement for Vaxelis from the US Advisory Committee on Immunization Practices (ACIP), a panel of experts that makes recommendations about the childhood vaccinations schedule (archived here). "It's an excellent vaccine," she told AFP in a June 2 email. In February 2019, the ACIP reported that Vaxelis was subjected to six clinical studies involving more than 5,000 infants six to 12 weeks of age (archived here). It said the studies showed Vaxelis "had an acceptable safety profile that is consistent with its component vaccines." Placebo testing Barke is correct that Vaxelis was not tested against an inert placebo. But experts said there is reason for that: it would have been unethical to do so. Clinical trial participants must be offered the existing standard of care, Moore said. It would be "entirely unethical" to withhold existing vaccines while testing a combination product that contains components already routinely given in those separate shots, she said. The World Health Organization has also pushed back against calls for changes to vaccination testing. "The safety of vaccines is held to an extremely high standard," WHO vaccine chief Kate O'Brien said May 1, 2025 (archived here). O'Brien stressed that the "gold standard" process calls for placebo testing when developing vaccines against diseases for which no immunization options exist. But when vaccines are developed to cover new strains or to offer a combination shot against multiple viruses, they are generally tested to see if they are as or more effective than the existing shots. O'Brien said it would also be unethical to give test subjects a placebo in place of "vaccines that are life-saving that are already licensed." Combination vaccines Barke further misleads by misinterpreting section 13.1 of the package insert, which says that Vaxelis was not evaluated for "carcinogenic or mutagenic potential or impairment of fertility." The language appears in documents for many routine vaccines, US health care group Novant Health explains on its website (archived here). "This merely means that there was no need for further testing because toxicology studies conducted at the preclinical phase showed no signs of adverse effects from the vaccine or its individual components," it says. There are also specific guidelines and rules for when a manufacturer needs to perform fertility studies. With a shot approved for use only in populations under five years old, studies in pregnant animals would not take place, said Kathryn Edwards, an expert in vaccinology at the Vanderbilt University Medical Center (archived here). "These vaccines have been used individually for decades in millions of people that there has not been a signal for infertility and no biologic reason why you would be concerned," she said in a June 4 email. Six-in-one shots, including Vaxelis, were developed to lower the number of injections for children, "reduce the burden of handling multiple different separate vaccines and to ensure timely administration of all the needed vaccines," Edwards said. The Canadian Paediatric Society and the Canadian National Advisory Committee on Immunization currently recommend children receive 5-in-1 or 6-in-1 vaccines (archived here and here). After a vaccine is approved, its safety continues to be monitored. "Combination vaccines have been shown to be no more reactive than separate vaccines, and no long term complications have been seen with combination vaccines," Edwards said. Such products have several advantages, including increased coverage rates, reduced need for additional health care visits and lower costs for distributing the product, according to the US Center for Disease Control and Prevention (archived here). Adverse effects Barke's video highlights the potential risk of Guillain-Barré syndrome -- a condition in which the body's immune system attacks the nerves, sometimes causing temporary paralysis. He also points to apnea, which is a pause in breathing, as a risk. But Edwards said Guillain-Barré syndrome is "very rare in children." Cedars Sinai Hospital says on its website that most children diagnosed with Guillain-Barré syndrome "recover fully with no complications" (archived here). Rachel Greenberg, associate professor of pediatrics at Duke University School of Medicine, researched apnea risks when vaccinating premature infants (archived here). "While there is a temporary increased risk of apnea after vaccination, the risk posed by vaccine-preventable respiratory and other infections to unvaccinated infants is far higher," she said in a press release about her January 2025 study (archived here). The most common side effects reported following a shot of Vaxelis are pain or swelling at the injection site and fever (archived here). Melody Butler, founding executive director of Nurses Who Vaccinate, said parents weighing the risk of rare, serious adverse events should remember how many children still die from vaccine-preventable diseases (archived here). "We've become so spoiled that we don't even know what these diseases do to the human body," she told AFP June 4. "We're very fortunate that we don't see these diseases firsthand." Ingredients Barke's video also targets the vaccine's ingredients, a tactic regularly deployed by activists who claim, without evidence, that immunizations are dangerous. In particular, he questions aluminum and formaldehyde. Aluminum is naturally found in the environment, and humans ingest it through drinking water and some foods, including breast milk and infant formula. Aluminum boosts immune response, reducing the amount of vaccine required to provide immunity (archived here). Aluminum-containing vaccines have been used for decades and have been administered to more than one billion people without problem, the Children's Hospital of Philadelphia (CHOP) says on its website (archived here). Formaldehyde, meanwhile, is "essential in human metabolism" and can be found in all humans, according to CHOP (archived here). It is used in vaccines to help prevent bacterial contamination during manufacturing (archived here). "There's more formaldehyde in a single apple or pear than in a vaccine," Butler said, dismissing the residual amounts passed to the body during vaccination as "negligible." Read more of AFP's reporting on vaccine misinformation here.

US health secretary ousts entire CDC vaccine advisory committee
US health secretary ousts entire CDC vaccine advisory committee

Euronews

timea day ago

  • Euronews

US health secretary ousts entire CDC vaccine advisory committee

US Health Secretary Robert F. Kennedy Jr has fired every member of a vital scientific committee, that advises the Centres for Disease Control and Prevention (CDC), on how to use vaccines, pledging to replace them with his own staff. His actions have come under the radar with various groups having criticised his decision, which they feel may endanger the future use of vaccines in the US. Major physicians in the country have slammed the decision to oust all 17 members of the panel. Tom Frieden, president and CEO of Resolve to Save Lives and former director of the CDC, accused Kennedy of 'politicising' the Advisory Committee on Immunisation Practices (ACIP), warning that it could undermine public trust established through years of commitment and hard work. 'We'll look back at this as a grave mistake that sacrificed decades of scientific rigour, undermined public trust, and opened the door for fringe theories rather than facts,' he added. But Kennedy insists the decision was taken on merit since several members had many conflicts of interest while they were holding a position on the board. Members are currently required to declare any potential such conflicts, as well as business interests, that arise during their tenure. They also must disclose any possible conflicts at the start of each public meeting. Although it's typically not viewed as a partisan board, the entire current roster of committee members were Biden appointees. The health secretary said in an op-ed for the Wall Street Journal that the Trump administration would not have been able to appoint new members until 2028 without removing the current roster. 'A clean sweep is needed to re-establish public confidence in vaccine science,' said Kennedy Jr. Frieden says the health secretary's actions were based on false conflict of interest claims and sets 'a dangerous and unprecedented action that makes our families less safe' by potentially reducing vaccine access for millions of people. Georges Benjamin of the American Public Health Association (APHA) called the ouster 'a coup.' Bruce Scott of the American Medical Association (AMA) warned the decision could lead to lower vaccination rates and more disease outbreaks. Scott also called the ACIP a trusted source of science- and data-driven advice and said Kennedy's move, coupled with declining vaccination rates across the country, will help drive an increase in vaccine-preventable diseases. Kennedy has long been a staunch critic of vaccination programmes, gaining popularity as one of the nation's leading anti-vaccine activists, prior to his appointment as top US health official. Last month, he changed the CDC's COVID-19 guidelines – without first consulting the committee – removing it as a recommended vaccination for children and pregnant women, leaving that decision in the hands of patients. Israeli Prime Minister Benjamin Netanyahu will hold a security meeting on Wednesday following his phone call with US President Donald Trump. Israeli media says the call between Trump and Netanyahu lasted around 40 minutes, with the pair discussing a wide range of topics, from the war on Gaza to developments in the Iran nuclear deal. Asked about his call with Netanyahu, Trump didn't offer much detail, but insisted that the call with the Israeli premier went well. "Very well. Yeah, we discussed a lot of things, and it went very well. Very smooth. We'll see what happens. You know, we're trying to do something with a country we just spoke about, Iran,' said Trump. Trump however revealed that negotiations appear to be stagnant due to the Iranians being 'good negotiators'. He also again warned that a violent US approach to Tehran is not off the table. 'Sometimes they can be too tough. That's the problem. So, we are trying to make a deal so that there's no destruction and death. And we've told them that, and I've told them that, and I hope that's the way it works out. But it might not work out that way." Joining the security meeting with Netanyahu – according to Israeli media – are Defence Minister Israel Katz, Shas party chairperson Aryeh Deri and Strategic Affairs Minister Ron Dermer. Far-right figures who will also reportedly be taking part in the meeting include National Security Minister Itamar Ben Gvir and Finance Minister Bezalel Smotrich. Ben Gvir and Smotrich are not typically included in such high-level meetings. The meeting comes as Tehran is expected to respond to Washington's proposal for a nuclear deal. The Iranian response is expected to arrive in the form of a counter to the US proposal. Washington has reportedly proposed to allow Tehran to continue enriching uranium, but at low levels and for a limited time period. This will then be halted when a consortium is established for the enrichment of uranium for Iran and other countries outside of Iranian territory. Tehran is expected to reject this proposal, with rumours emerging that Iranian officials will not accept a deal in which they're told what to do on their own territory.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store